GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LSE:0HKE) » Definitions » Shiller PE Ratio

Novartis AG (LSE:0HKE) Shiller PE Ratio : (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Novartis AG Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novartis AG Shiller PE Ratio Historical Data

The historical data trend for Novartis AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Shiller PE Ratio Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.84 19.66 16.02 16.45 16.42

Novartis AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.22 17.37 18.16 16.42 16.89

Competitive Comparison of Novartis AG's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Novartis AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Shiller PE Ratio falls into.



Novartis AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis AG's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Novartis AG's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/106.4611*106.4611
=0.000

Current CPI (Mar. 2024) = 106.4611.

Novartis AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.000 101.517 0.000
201409 0.000 101.247 0.000
201412 0.000 100.704 0.000
201503 0.000 100.339 0.000
201506 0.000 100.464 0.000
201509 0.000 99.785 0.000
201512 0.000 99.386 0.000
201603 0.000 99.475 0.000
201606 0.000 100.088 0.000
201609 0.000 99.604 0.000
201612 0.000 99.380 0.000
201703 0.000 100.040 0.000
201706 0.000 100.285 0.000
201709 0.000 100.254 0.000
201712 0.000 100.213 0.000
201803 0.000 100.836 0.000
201806 0.000 101.435 0.000
201809 0.000 101.246 0.000
201812 0.000 100.906 0.000
201903 0.000 101.571 0.000
201906 0.000 102.044 0.000
201909 0.000 101.396 0.000
201912 0.000 101.063 0.000
202003 0.000 101.048 0.000
202006 0.000 100.743 0.000
202009 0.000 100.585 0.000
202012 0.000 100.241 0.000
202103 0.000 100.800 0.000
202106 0.000 101.352 0.000
202109 0.000 101.533 0.000
202112 0.000 101.776 0.000
202203 0.000 103.205 0.000
202206 0.000 104.783 0.000
202209 0.000 104.835 0.000
202212 0.000 104.666 0.000
202303 0.000 106.245 0.000
202306 0.000 106.576 0.000
202309 0.000 106.570 0.000
202312 0.000 106.461 0.000
202403 0.000 106.461 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novartis AG  (LSE:0HKE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novartis AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novartis AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (LSE:0HKE) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (LSE:0HKE) Headlines

No Headlines